Clinical Trial: A Study to Evaluate the Intracranial Arterial Recanalization With Multiple Doses of LT3001 Drug Product in AIS Participant

U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07890298) titled 'A Study to Evaluate the Intracranial Arterial Recanalization With Multiple Doses of LT3001 Drug Product in AIS Participant' on Oct. 16.

Brief Summary: This is a phase II, open-label, single-arm, exploratory study to evaluate the intracranial arterial recanalization of multiple doses of LT3001 drug product in participant with acute ischemic stroke (AIS)

Study Start Date: Oct. 01

Study Type: INTERVENTIONAL

Condition: Acute Ischemic Stroke

Intervention: DRUG: LT3001 Drug Product

Administered by intravenous infusion

Recruitment Status: RECRUITING

Sponsor: Lumosa Therapeutics Co., Ltd.

Published by HT Digital Content Services w...